pharmaceuticals

US

US hedge fund suffers $2bn losses from Allergan and Valeant bets

John Paulson saw losses over five months

clock 20 April 2016 • 1 min read

UK

Burberry falls 6% after dip in European sales

Shoppers deterred by terrorist attacks

clock 14 April 2016 • 1 min read

Commodities

The big turnaround stories of Q1... and the major sector laggards

Gold funds top performance charts

clock 11 April 2016 • 3 min read

Investment Trusts

Revealed: The best and worst trusts in Q1

Winterflood's latest review

clock 08 April 2016 • 2 min read

US

Pfizer calls off $160bn Allergan merger on US tax changes - reports

Crackdown on domicile changes

clock 06 April 2016 • 1 min read

Specialist

Is healthcare investment really best left until after the US election?

Biotech has fallen

clock 29 March 2016 • 2 min read

Investment Trusts

Three lions and a dog: Three healthcare companies you cannot buy - and one you do not want

The Merchants trust's Simon Gergel explains why investing in one of the UK's biggest healthcare stocks - GlaxoSmithKline - is not as simple as many investors envisage

clock 14 March 2016 • 4 min read

Alternatives

How useful are specialist sector funds and what are the risks?

Hardeep Tawakley takes a closer look at the evolution of specialist funds and speaks to buyers about their favourite offerings.

clock 14 March 2016 • 7 min read

UK

Woodford IM: Our outlook for top ten biggest holdings

L&G and Glaxo under the microscope

clock 07 March 2016 • 2 min read

Funds

One to Watch: Miton's Moore on negotiating the Mott handover

Moore succeeds Mott on fund

clock 07 March 2016 • 3 min read
Trustpilot